Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06666608 · ClinicalTrials.gov registry record · NA

Bone Stimulator for Spondylolysis

A NA study of Spondylolysis and Symptomatic Spondylolysis, sponsored by The Methodist Hospital Research Institute.

Recruiting
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT06666608: Recruiting NA study of Spondylolysis and Symptomatic Spondylolysis, sponsored by The Methodist Hospital Research Institute.

NCT06666608 is a NA study of Spondylolysis and Symptomatic Spondylolysis that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 48 participants, below the 79-participant average among 3 other Spondylolysis trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06666608, a NA study of Spondylolysis and Symptomatic Spondylolysis, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.

RECRUITING
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide valuable insights into the role of bone stimulation therapy as a potential treatment modality for this challenging condition.

Primary Outcome

This outcome will be evaluated via REDCap with a Return to Sport Questionnaire, which will ask what sport(s) participant played prior to injury, if they have returned to the sports they played prior to back injury, what level of sports they returned to (recreational, organized, professional), what level of play they have returned to (same as before injury, higher than before injury, or lower than before injury), and if they report that they did not return to sport, what the reason was. This outc

Interventions

  • DEVICE Bone Stimulator
  • OTHER Standard of Care Spondylolysis Treatment

Study Locations (1)

Texas

  • Houston Methodist Hospital - Houston

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2025-09
Est. Completion 2029-12
Phase NA

What NCT06666608 shows while recruiting

NCT06666608 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 79-participant average among 3 other Spondylolysis trials with a reported enrollment target (39% lower).

The record links to 3 conditions, with Spondylolysis appearing as the primary indexed condition, and to 2 interventions - of which Bone Stimulator is the first listed.

NCT06666608 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06666608 about?

NCT06666608 is a clinical study titled "Bone Stimulator for Spondylolysis". This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide va...

What is the current status of trial NCT06666608?

This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2025-09. Estimated completion is 2029-12.

What conditions does trial NCT06666608 study?

This clinical trial studies the following conditions: Spondylolysis, Symptomatic Spondylolysis, Athletes.

What interventions are being tested in trial NCT06666608?

The interventions under investigation include: Bone Stimulator (DEVICE), Standard of Care Spondylolysis Treatment (OTHER).

Who is sponsoring clinical trial NCT06666608?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06666608 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spondylolysis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06666608, the US trial registry maintained by the National Library of Medicine. NCT06666608 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.